Potential IPR Probe of L-Tryptophan Evaluated for Public Interest Issues
The International Trade Commission received May 10 on behalf of Immersion Corporation a petition requesting that it institute a Section 337 investigation regarding L-tryptophan, L-tryptophan products and their methods of production. The proposed respondents are located in Korea, Indonesia and the U.S.
The ITC is requesting comments no later than May 24 on any public interest issues raised by this complaint. Comments should address whether the issuance of the exclusion order and cease and desist orders requested by the complainant would affect the public health and welfare in the U.S., competitive conditions in the U.S. economy, the production of like or directly competitive articles in the U.S., or U.S. consumers. In particular, the ITC is interested in comments that:
- explain how the articles potentially subject to the orders are used in the U.S.;
- identify any public health, safety or welfare concerns in the U.S. relating to the potential orders;
- identify like or directly competitive articles that the complainant, its licensees or third parties make in the U.S. that could replace the subject articles if they were to be excluded;
- indicate whether the complainant, its licensees and/or third-party suppliers have the capacity to replace the volume of articles potentially subject to the requested orders within a commercially reasonable time; and
- explain how the requested orders would impact U.S. consumers.